Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb study.
Beier J, Kirsten AM, Mróz R, Segarra R, Chuecos F, Caracta C, Gil EG. Beier J, et al. Among authors: segarra r. COPD. 2013 Aug;10(4):511-22. doi: 10.3109/15412555.2013.814626. Epub 2013 Jul 2. COPD. 2013. PMID: 23819698 Free PMC article. Clinical Trial.
AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD.
Sethi S, Kerwin E, Watz H, Ferguson GT, Mroz RM, Segarra R, Molins E, Jarreta D, Garcia Gil E. Sethi S, et al. Among authors: segarra r. Int J Chron Obstruct Pulmon Dis. 2019 Mar 22;14:667-682. doi: 10.2147/COPD.S189138. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 30962681 Free PMC article. Clinical Trial.
The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study.
Smith JA, McGarvey L, Morice AH, Birring SS, Wedzicha JA, Notari M, Zapata A, Segarra R, Seoane B, Jarreta D. Smith JA, et al. Among authors: segarra r. Am J Respir Crit Care Med. 2019 Sep 1;200(5):642-645. doi: 10.1164/rccm.201901-0048LE. Am J Respir Crit Care Med. 2019. PMID: 30951372 Free PMC article. Clinical Trial. No abstract available.
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study.
Amoretti S, Mezquida G, Verdolini N, Bioque M, Sánchez-Torres AM, Pina-Camacho L, Zorrilla I, Trabsa A, Rodriguez-Jimenez R, Corripio I, Sarró S, Ibañez A, Usall J, Segarra R, Vieta E, Roberto N, Ramos-Quiroga JA, Tortorella A, Menculini G, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Bernardo M; 2EPs Group; Annex. Members of the 2EPs group. Amoretti S, et al. Among authors: segarra r. Span J Psychiatry Ment Health. 2023 Sep 14:S2950-2853(23)00010-8. doi: 10.1016/j.sjpmh.2023.04.001. Online ahead of print. Span J Psychiatry Ment Health. 2023. PMID: 38591832
61 results